Essex Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Essex Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-77,077	Closed	-$2.07M	–	379
2017 Q1	$2.07M	Buy	77,077 +10,566	+16%	+$292K	0.32%	84
2016 Q4	$1.74M	Sell	66,511 -20,216	-23%	-$500K	0.29%	97
2016 Q3	$2.17M	Buy	86,727 +35,268	+69%	+$822K	0.35%	71
2016 Q2	$1.12M	Sell	51,459 -399	-0.8%	-$7.12K	0.19%	126
2016 Q1	$777K	Sell	51,858 -1,279	-2%	-$21.4K	0.13%	165
2015 Q4	$1.16M	Buy	+53,137	New	+$990K	0.18%	133
2013 Q3	–	Sell	-16,580	Closed	-$237K	–	397
2013 Q2	$237K	Buy	+16,580	New	+$209K	0.04%	304

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Essex Investment Management's NXTM Position: Q2 2017 in Review

Essex Investment Management sold out of NxStage Medical Inc. (NXTM) in Q2 2017, closing a stake of 77,077 shares — an estimated $2.07M sold.

Essex Investment Management first reported a position in NXTM in Q2 2013 and held it in 7 quarters. The position peaked at $2.17M in Q3 2016. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

Essex Investment Management reported no remaining NxStage Medical Inc. position as of Q2 2017 after selling out during the quarter.
Essex Investment Management sold 77,077 NxStage Medical Inc. shares in Q2 2017, an estimated $2.07M.
Essex Investment Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 7 quarters.
Essex Investment Management's NxStage Medical Inc. position peaked at $2.17M in Q3 2016.
163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Essex Investment Management's 13F filing for Q2 2017, filed 28 Jul 2017.